| 1E3G | A: | HUMAN ANDROGEN RECEPTOR LIGAND BINDING IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881) |
| 1GS4 | A: | STRUCTURAL BASIS FOR THE GLUCOCORTICOID RESPONSE IN A MUTANT HUMAN ANDROGEN RECEPTOR (ARCCR) DERIVED FROM AN ANDROGEN-INDEPENDENT PROSTATE CANCER |
| 1T5Z | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70 |
| 1T63 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3 |
| 1T65 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION |
| 1XOW | A: | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2-TERMINAL PEPTIDE, AR20-30, AND R1881 |
| 1XQ3 | A: | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881 |
| 2AM9 | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TESTOSTERONE |
| 2AMA | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH DIHYDROTESTOSTERONE |
| 2AMB | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TETRAHYDROGESTRINONE |
| 2AO6 | A: | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881 |
| 2AX6 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH HYDROXYFLUTAMIDE |
| 2AX7 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH S-1 |
| 2AX8 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN W741L MUTANT IN COMPLEX WITH S-1 |
| 2AX9 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH R-3 |
| 2AXA | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH S-1 |
| 2HVC | A: | THE CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN (LBD) OF HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE MODULATOR LGD2226 |
| 2OZ7 | A: | CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR T877A MUTANT LIGAND-BINDING DOMAIN WITH CYPROTERONE ACETATE |
| 2PIO | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIP | L: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIQ | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIR | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIT | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIU | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PIV | A: | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
| 2PIW | A: | ANDROGEN RECEPTOR WITH SMALL MOLECULE |
| 2PIX | A: | AR LBD WITH SMALL MOLECULE |
| 2PKL | A: | ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE |
| 2PNU | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH EM-5744 |
| 2Q7I | A: | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
| 2Q7J | A: | THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753 |
| 2Q7K | A: | THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE |
| 2Q7L | A: | THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX3 COACTIVATOR PEPTIDE 740-753 |
| 2YHD | A: | HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH AF2 SMALL MOLECULE INHIBITOR |
| 2Z4J | A: | CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2 |
| 3B5R | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-31 |
| 3B65 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-24 |
| 3B66 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-21 |
| 3B67 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-23 |
| 3B68 | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-4 |
| 3L3X | A: | CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE FIRST MOTIF OF STEROID RECEPTOR COACTIVATOR 3 |
| 3L3Z | A: | CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE THIRD MOTIF OF STEROID RECEPTOR COACTIVATOR 3 |
| 3RLJ | A: | CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-22 |
| 3RLL | A: | CRYSTAL STRUCTURE OF THE T877A ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH (S)-N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-CYANONAPHTHALEN-1-YLOXY)-2-HYDROXY-2-METHYLPROPANAMIDE |
| 4HLW | A: | TARGETING THE BINDING FUNCTION 3 (BF3) SITE OF THE HUMAN ANDROGEN RECEPTOR THROUGH VIRTUAL SCREENING. 2. DEVELOPMENT OF 2-((2-PHENOXYETHYL) THIO)-1H-BENZOIMIDAZOLE DERIVATIVES. |
)
)